Gene co-expression networks are associated with obesity-related traits in kidney transplant recipients

Rosario B Jaime-Lara1, Abhrarup Roy1, Yupeng Wang2

  • 1Division of Intramural Research, National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, 20892, USA.

BMC Medical Genomics
|March 11, 2020
PubMed
Abstract

Insights

Obesity mechanisms in kidney transplant recipients were explored using gene co-expression analysis. Two gene modules linked to obesity traits were identified, offering insights into cellular processes influencing weight in this patient group.

Area of Science:

  • Genomics
  • Transplantation Medicine
  • Metabolic Research

Background:

  • Obesity is prevalent in kidney transplant recipients, but its underlying biological mechanisms remain unclear.
  • Subcutaneous adipose tissue, accessible during surgery, offers a valuable resource for studying obesity in this population.
  • Gene co-expression analysis provides a systems-level perspective on coordinated gene activity, complementing differential gene expression studies.

Purpose of the Study:

  • To investigate gene co-expression patterns associated with obesity in kidney transplant recipients.
  • To identify specific gene modules and biological processes linked to obesity-related traits in this cohort.
  • To gain a deeper understanding of the molecular underpinnings of obesity in the context of kidney transplantation.

Main Methods:

  • Collected demographic, clinical, and microarray gene expression data from 26 kidney transplant patients.
  • Applied Weighted Gene Correlation Network Analysis (WGCNA) to 5758 highly expressed genes.
  • Correlated gene co-expression modules with obesity-related clinical traits.

Main Results:

  • Identified 35 co-expression modules, with two significantly associated with obesity traits at baseline.
  • Performed Gene Ontology (GO) enrichment analysis on the identified modules.
  • One module (129 genes) was enriched for cellular homeostasis and immune responses; another (36 genes) for tissue development.

Conclusions:

  • Generated novel gene co-expression modules linked to obesity in kidney transplant recipients.
  • Provided new insights into the cellular and biological processes contributing to obesity in this specific patient population.
  • Highlighted the potential of adipose tissue gene expression analysis for understanding obesity in transplant recipients.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
266
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
123
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
189
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
480